Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.
Kuyama N, Takashio S, Oguni T, Yamamoto M, Hirakawa K, Ishii M, Hanatani S, Oda S, Matsuzawa Y, Usuku H, Yamamoto E, Hirai T, Ueda M, Tsujita K.
Kuyama N, et al. Among authors: hirakawa k.
J Am Heart Assoc. 2024 May 21;13(10):e034518. doi: 10.1161/JAHA.124.034518. Epub 2024 May 18.
J Am Heart Assoc. 2024.
PMID: 38761073
Free article.